# Lithium Versus Paroxetine in Major Depression

> **NCT01416220** · PHASE4 · WITHDRAWN · sponsor: **Nova Scotia Health Authority**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Lithium
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT01416220
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416220, "Lithium Versus Paroxetine in Major Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01416220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*